uniQure N.V. (QURE) Stock Forecast
Data as of Sep 16, 2026Healthcare · Current price $42.00 (-2.55%)
Price Target Range
Consensus Price Target Over Time
Analyst Rating Distribution
Last 3 Months
6-Month Trend
Latest Analyst Forecasts
Price targets issued by Wall Street analysts. Upside calculated against today's price.
| Date | Analyst | Firm | Price Target | Upside |
|---|---|---|---|---|
| Mar 9, 2026 | Daniil Gataulin | Chardan Capital | $31.00 | -26.2% |
| Mar 9, 2026 | Yanan Zhu | Wells Fargo | $60.00 | +42.9% |
| Mar 9, 2026 | Luca Issi | RBC Capital | $35.00 | -16.7% |
| Mar 2, 2026 | Joseph Schwartz | Leerink Partners | $35.00 | -16.7% |
| Mar 2, 2026 | Luca Issi | RBC Capital | $11.00 | -73.8% |
| Mar 2, 2026 | Paul Matteis | Stifel Nicolaus | $14.00 | -66.7% |
| Dec 8, 2025 | Uy Ear | Mizuho Securities | $33.00 | -21.4% |
| Nov 4, 2025 | Patrick Trucchio | H.C. Wainwright | $70.00 | +66.7% |
| Nov 3, 2025 | Daniil Gataulin | Chardan Capital | $53.00 | +26.2% |
| Sep 25, 2025 | Uy Ear | Mizuho Securities | $60.00 | +42.9% |
| Jan 7, 2025 | Luca Issi | RBC Capital | $24.00 | -42.9% |
| Aug 8, 2022 | Matthew Barcus | Chardan Capital | $60.00 | +42.9% |
| Jan 7, 2022 | Yanan Zhu | Wells Fargo | $34.00 | -19.0% |
| Dec 16, 2021 | Danielle Brill | Raymond James | $58.00 | +38.1% |
| Oct 28, 2021 | Suji Jeong | Jefferies | $62.00 | +47.6% |
Top Analysts Covering QURE
QURE vs Sector & Market
| Metric | QURE | Healthcare Avg | Large Cap Avg |
|---|---|---|---|
| Analyst Rating | 2.23 | 2.25 | 2.42 |
| Analyst Count | 13 | 8 | 18 |
| Target Upside | +28.1% | +16187.2% | +19.5% |
| P/E Ratio | -5.22 | 3.79 | 38.67 |
Revenue Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $5M | $7M | $11M | 5 |
| 2027-03-31 | $5M | $7M | $11M | 3 |
| 2027-06-30 | $5M | $8M | $11M | 3 |
| 2027-09-30 | $5M | $8M | $12M | 3 |
| 2027-12-31 | $6M | $8M | $12M | 3 |
| 2028-03-31 | $2M | $2M | $3M | 2 |
| 2028-06-30 | $1M | $2M | $3M | 2 |
| 2028-09-30 | $1M | $2M | $3M | 2 |
| 2028-12-31 | $74M | $178M | $391M | 8 |
| 2029-12-31 | $155M | $371M | $816M | 7 |
| 2030-12-31 | $243M | $582M | $1.28B | 7 |
EPS Estimates
| Period | Low | Avg | High | # |
|---|---|---|---|---|
| 2026-12-31 | $-1.56 | $-0.93 | $-0.59 | 4 |
| 2027-03-31 | $-3.03 | $-1.81 | $-1.15 | 2 |
| 2027-06-30 | $-1.52 | $-0.91 | $-0.58 | 2 |
| 2027-09-30 | $-1.57 | $-0.94 | $-0.60 | 2 |
| 2027-12-31 | $-1.55 | $-0.92 | $-0.59 | 2 |
| 2028-03-31 | $-1.47 | $-0.88 | $-0.56 | 3 |
| 2028-06-30 | $-1.52 | $-0.91 | $-0.58 | 3 |
| 2028-09-30 | $-1.61 | $-0.96 | $-0.61 | 3 |
| 2028-12-31 | $-4.41 | $-2.60 | $1.21 | 7 |
| 2029-12-31 | $-1.43 | $-0.56 | $-0.14 | 2 |
| 2030-12-31 | $0.37 | $1.52 | $3.89 | 5 |
Frequently Asked Questions
What is the analyst consensus for QURE?
The consensus among 13 analysts covering uniQure N.V. (QURE) is Buy with an average price target of $58.00.
What is the highest price target for QURE?
The highest price target for QURE is $70.00, set by Patrick Trucchio at H.C. Wainwright on 2025-11-04.
What is the lowest price target for QURE?
The lowest price target for QURE is $11.00, set by Luca Issi at RBC Capital on 2026-03-02.
How many analysts cover QURE?
13 analysts have issued ratings for uniQure N.V. in the past 12 months.
Is QURE a buy or sell right now?
Based on 13 analyst ratings, QURE has a consensus rating of Buy (2.23/5) with a +28.1% upside to the consensus target of $58.00.
What are the earnings estimates for QURE?
Analysts estimate QURE will report EPS of $-0.93 for the period ending 2026-12-31, with revenue estimated at $7M.
Related Stock Forecasts
Data updated daily. Analyst price targets sourced from public filings and broker reports. Not investment advice.